P-272 The international, open-label, multicenter phase 2 LAPACT trial of nab-paclitaxel (nab-P) plus gemcitabine (Gem) for patients with locally advanced pancreatic cancer (LAPC)

od Pascal, Hammel, Jill, Lacy, Fabienne, Portales, Alberto, Sobrero, Beatriz, García-Paredes, Edward, Kim, Fernando, Rivera, Luis, Manzano Jose, Eric, Terrebonne, Venu, Bathini, Scot, Dowden, Jamil, Asselah, Jack, Shiansong Li, Thomas, Nydam, Louis, Kayitalire, Philip, Philip
Izdano u Ann Oncol (2016)